2/25
06:00 am
snse
Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
1/7
08:00 am
snse
Egle Therapeutics Appoints John Celebi as Chief Executive Officer
Medium
Report
Egle Therapeutics Appoints John Celebi as Chief Executive Officer
12/27
01:05 am
snse
Sensei Biotherapeutics (NASDAQ:SNSE) was upgraded by analysts at
Wall St
Low
Report
Sensei Biotherapeutics (NASDAQ:SNSE) was upgraded by analysts at
Wall St